Published in J Hum Genet on August 21, 2014
A pilot study of gene testing of genetic bone dysplasia using targeted next-generation sequencing. J Hum Genet (2015) 0.78
Two Patients with Severe Short Stature due to a FBN1 Mutation (p.Ala1728Val) with a Mild Form of Acromicric Dysplasia. Horm Res Paediatr (2016) 0.75
Acromicric Dysplasia Caused by a Novel Heterozygous Mutation of FBN1 and Effects of Growth Hormone Treatment. Ann Lab Med (2017) 0.75
Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature (1991) 11.44
Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome. Nat Genet (2003) 11.01
Effect of mutation type and location on clinical outcome in 1,013 probands with Marfan syndrome or related phenotypes and FBN1 mutations: an international study. Am J Hum Genet (2007) 2.91
Clinical homogeneity and genetic heterogeneity in Weill-Marchesani syndrome. Am J Med Genet A (2003) 1.79
ADAMTSL2 mutations in geleophysic dysplasia demonstrate a role for ADAMTS-like proteins in TGF-beta bioavailability regulation. Nat Genet (2008) 1.78
Homozygous mutations in ADAMTS10 and ADAMTS17 cause lenticular myopia, ectopia lentis, glaucoma, spherophakia, and short stature. Am J Hum Genet (2009) 1.73
Mutations in the TGFβ binding-protein-like domain 5 of FBN1 are responsible for acromicric and geleophysic dysplasias. Am J Hum Genet (2011) 1.55
Cell adhesion to fibrillin-1: identification of an Arg-Gly-Asp-dependent synergy region and a heparin-binding site that regulates focal adhesion formation. J Cell Sci (2007) 1.08
Geleophysic dwarfism--a "focal" mucopolysaccharidosis? Lancet (1971) 1.06
Genetic and functional linkage between ADAMTS superfamily proteins and fibrillin-1: a novel mechanism influencing microfibril assembly and function. Cell Mol Life Sci (2011) 1.02
Molecular screening of ADAMTSL2 gene in 33 patients reveals the genetic heterogeneity of geleophysic dysplasia. J Med Genet (2011) 1.02
Acromicric dysplasia: long term outcome and evidence of autosomal dominant inheritance. J Med Genet (2001) 0.96
Fibrillin-1 mutations causing Weill-Marchesani syndrome and acromicric and geleophysic dysplasias disrupt heparan sulfate interactions. PLoS One (2012) 0.92
More than meets the eye: The evolving phenotype of Weill-Marchesani syndrome-diagnostic confusion with geleophysic dysplasia. Am J Med Genet A (2013) 0.86
Missense mutations in FBN1 exons 41 and 42 cause Weill-Marchesani syndrome with thoracic aortic disease and Marfan syndrome. Am J Med Genet A (2013) 0.86
Geleophysic dysplasia: 7-year follow-up study of a patient with an intermediate form. Am J Med Genet (1999) 0.85
Acromicric dysplasia and geleophysic dysplasia: similarities and differences. Eur J Pediatr (1996) 0.85
A Japanese child with geleophysic dysplasia caused by a novel mutation of FBN1. Gene (2012) 0.82
Natural history of cardiac involvement in geleophysic dysplasia. Am J Med Genet A (2005) 0.82
Immunolocalisation of fibrillin microfibrils in the calf metacarpal and vertebral growth plate. J Anat (2013) 0.81
Geleophysic dysplasia: a patient with a severe form of the disorder. J Obstet Gynaecol (2005) 0.79
Clinical and morphological phenotype of geleophysic dysplasia. Ann Trop Paediatr (2008) 0.79
A pilot study of gene testing of genetic bone dysplasia using targeted next-generation sequencing. J Hum Genet (2015) 0.78
Successful newborn screening for Gaucher disease using fluorometric assay in China. J Hum Genet (2017) 0.75
A new case of malonyl-CoA decarboxylase deficiency with mild clinical features. Am J Med Genet A (2016) 0.75